Home › Funds › D. E. Shaw & Co › AZN
D. E. Shaw & Co position in AZN
ASTRAZENECA PLC · Health Care
D. E. Shaw & Co reported holding 4,775,972 shares of AZN (ASTRAZENECA PLC) in its Q3 2026 13F filing — a position valued at US$771.2M, representing 1.09% of its reported portfolio and ranking #4 among its reported holdings. D. E. Shaw & Co has disclosed AZN holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How D. E. Shaw & Co's AZN position evolved
D. E. Shaw & Co first disclosed a stake in AZN in Q3 2021 at 1,373,944 shares (US$82.5M). The position peaked in Q3 2026 at 4,775,972 shares, worth US$771.2M. Across 21 filings, D. E. Shaw & Co increased the stake 11 time(s), trimmed it 9 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 4,775,972 shares valued at US$771.2M — an increase of 3,681,379 shares quarter over quarter.. Notable position changes include a 3454% increase in Q3 2022 (shares rose 24% over the following quarter), a 3130% increase in Q3 2024 (shares fell 16% over the following quarter), a 4277% increase in Q2 2026 (shares fell 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.37M | $82.52M | New |
| Q4 2021 | 909.98K | $53.01M | Reduce |
| Q1 2022 | 236.95K | $15.72M | Reduce |
| Q2 2022 | 9.84K | $650.00K | Reduce |
| Q3 2022 | 349.87K | $19.19M | Add |
| Q4 2022 | 665.91K | $45.15M | Add |
| Q1 2023 | 22.86K | $1.59M | Reduce |
| Q2 2023 | 43.41K | $3.11M | Add |
| Q3 2023 | 720.28K | $48.78M | Add |
| Q4 2023 | 1.57M | $105.59M | Add |
| Q1 2024 | 16.72K | $1.13M | Reduce |
| Q2 2024 | 50.15K | $3.91M | Add |
| Q3 2024 | 1.62M | $126.20M | Add |
| Q4 2024 | 4.84M | $317.36M | Add |
| Q1 2025 | 1.70M | $125.00M | Reduce |
| Q2 2025 | 1.97M | $137.58M | Add |
| Q3 2025 | 246.53K | $18.91M | Reduce |
| Q4 2025 | 53.24K | $4.89M | Reduce |
| Q1 2026 | 25.00K | $4.93M | Reduce |
| Q2 2026 | 1.09M | $207.56M | Add |
| Q3 2026 | 4.78M | $771.18M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AZN and 13F data
AZN (ASTRAZENECA PLC) is a Health Care company. 56 other funds we track also report a position in AZN — the largest reported positions include INVESTOR AB (US$8.33B), Norges Bank Investment Management (US$6.33B), Capital World Investors (US$5.06B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AZN
- INVESTOR AB 51.59M sh · $8.33B · Q3 2026
- Norges Bank Investment Management 33.86M sh · $6.33B · Q2 2026
- Capital World Investors 31.09M sh · $5.06B · Q3 2026
- Capital World Investors 31.09M sh · $5.06B · Q3 2026
- WELLINGTON MANAGEMENT GROUP LLP 30.84M sh · $5.01B · Q3 2026
- Wellington Management Group 30.84M sh · $5.01B · Q3 2026
- Legal & General Investment Management America 26.18M sh · $4.27B · Q3 2026
- Franklin Resources 19.05M sh · $3.59B · Q3 2026
- VANGUARD ASSET MANAGEMENT, Ltd 19.12M sh · $3.09B · Q3 2026
- PRIMECAP MANAGEMENT CO/CA/ 18.11M sh · $2.92B · Q3 2026
- Amundi US 17.12M sh · $2.76B · Q3 2026
- Capital International Investors 15.89M sh · $2.59B · Q3 2026
More on D. E. Shaw & Co
FAQ
How long has D. E. Shaw & Co held AZN?
D. E. Shaw & Co has disclosed AZN holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
What is D. E. Shaw & Co's current position in AZN?
As of Q3 2026, D. E. Shaw & Co holds 4.78M shares of AZN (ASTRAZENECA PLC), valued at $771.18M, representing 1.09% of its reported portfolio and ranking #4.
Has D. E. Shaw & Co been buying or selling AZN?
In the latest 13F filing (Q3 2026), D. E. Shaw & Co increased its position in AZN. The position peaked in Q3 2026 at 4.78M shares.
Which other funds hold AZN?
Other major institutional holders of AZN include INVESTOR AB, Norges Bank Investment Management, Capital World Investors, among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.